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Endoscopic ultrasound-guided access to the bile duct: A new frontier
Frank Weilert, 1 Kenneth F. Binmoeller 2,*
a b s t r a c t
Endoscopic retrograde cholangiopancreatography (ERCP) may fail in 10–15% of cases. These patients are usually referred for percutaneous transhepatic
biliary drainage (PTBD) or surgical interventions. Endoscopic ultrasound (EUS) offers an alternative route of access to the biliary tree. Using the curved
linear array echoendoscope, access to the bile duct is possible under real-time EUS guidance. The route of access is anterograde, in contrast to the
retrograde approach of ERCP. We have coined the term EUS-guided anterograde cholangiopancreatography (EACP) to cover the spectrum of EUS-guided
techniques for accessing and draining the bile and pancreatic ducts. The possible approaches and techniques are reviewed in this paper. The literature
supports the feasibility of EACP for malignant and benign biliary obstruction, with high success rates and improving safety proﬁle with regard to
signiﬁcant complications. Tools are being designed for EUS-guided applications to enable safer transenteric access and drainage.
Copyright  2012, Society of Gastrointestinal Intervention. Published by Elsevier. All rights reserved.
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Endoscopic retrograde cholangiopancreatography (ERCP)
enables the diagnosis and therapy of pancreaticobiliary disease and
is the preferred approach todrain anobstructed bile duct.1However,
in 10–15% of cases endoscopic biliary access may fail (Table 1).
Patients requiring biliary drainage are usually referred for percuta-
neous transhepatic biliary drainage (PTBD) or surgical bypass. These
approaches carry signiﬁcantly higher morbidity andmortality rates
compared with ERCP and transpapillary drainage.2,3 Endoscopic
ultrasound (EUS) has developed since the 1980s from a niche tool
into an interventional platform to intersect traditional boundaries
between interventional radiology and minimally invasive surgery.
This is exempliﬁed in the developments of pseudocyst drainage and
celiac neurolysis that are now well established. EUS combines real-
time imaging with interventional endoscopy capabilities and
thereby offers an alternative route to access and treat bile duct
obstruction.4
Background
Real-time visualization of the needle to access the bile duct
has been made possible with the advent of the curved linear
array echoendoscope in the 1990s. EUS-guided chol-
angiopancreatography was ﬁrst described in 1996.4 Since then,1 Peter Stokes Endoscopy Unit, Waikato District Health Board, Waikato Hospital, Hamilton, N
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The route of access is anterograde, in contrast to the retrograde
approach of ERCP. We have coined the term EUS-guided antero-
grade cholangiopancreatography (EACP) to cover the spectrum of
EUS-guided techniques for accessing and draining the bile ducts
(Table 2). Patients with known difﬁcult anatomy (e.g., altered
anatomy, or gastric outlet obstruction) or prior failed ductal access
are more likely to require EACP. All patients referred for thera-
peutic ERCP should give consent for both ERCP and EACP,
because it is impossible to predict when ERCP might fail and
EACP will be required.
EACP versus PTBD
EACP has several theoretical advantages over PTBD. Drainage is
internal, and thereby eliminates problems with external percu-
taneous drainage, including local skin pain, infection, drain care,
and bile loss. EACP is not limited by obesity, and less limited by
ascites than PTBD. Ultrasound guidance and the use of color
Doppler improve the safety proﬁle of EACP by avoiding vessels.
Practical advantages are the ability to perform EACP in the same
session as failed ERCP. In our departments the same operator
performs ERCP and EACP in the same session. EACP provides
excellent access to the left lobe, which can be limited by PTBD.
However, access to the right lobe with EACP is limited.ew Zealand
er, San Francisco, CA, USA
Center, 2351 Clay Street, Suite 600, San Francisco, CA 94115, USA.
on. Published by Elsevier. All rights reserved.
Table 1 Causes of Failed Retrograde Access to the Bile Ducts
Failed ductal cannulation
Unidentiﬁable papilla
Tumor inﬁltration of the papilla
Juxtapapillary diverticulum
High-grade stricture
Difﬁcult anatomy
Inability to reach the papilla (or ductal anastomosis)
Gastric outlet obstruction
High-grade duodenal stenosis
Post-peptic changes
Post-surgical anatomy
Gastrectomy
Gastric bypass
Whipple
Hepaticojejunostomy
Billroth II
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There are theoretical advantages of EACP over ERCP. By avoid-
ing the ampulla and accidental cannulation or injection of the
pancreatic duct, EACP eliminates the risk of pancreatitis. Currently,
EACP is reserved for failed ERCP but could eliminate the problem
of difﬁcult cannulation altogether if used as a primary access
strategy. Anterograde transenteric drainage can obviate all
instrumentation (wire passage, dilation and stenting) of the
downstream stricture. Creating a natural ﬁstula at a distance from
the obstructing tumor resolves the problem of tumor ingrowth
and overgrowth, which can cause stent obstruction, and it may
resolve the problem of stent clogging.
Prerequisities for EACP
The decision to pursue EACP should be made on a case-by-case
basis at the time of failed ERCP by the endoscopist, taking into
account the underlying clinical indication and condition of each
patient. All patients in whom EACP procedures are considered
must be suitable for EUS-guided ﬁne-needle aspiration (EUS-FNA)
and therapeutic ERCP (e.g., no bleeding diatheses, large volume
ascites, or other condition precluding EUS-FNA or therapeutic
ERCP).
Ideally, all procedures should be performed under monitored
anesthesia care with propofol or general anesthesia to allow
adequate time for completion of the interventions. Antibiotics
(ciproﬂoxacin or a third-generation cephalosporin) are routinely
administered prior to EACP to minimize the risk of peritonitis from
leakage of ductal or enteric contents at the transmural puncture
site. Oral antibiotics are continued for a minimum of 3 days after
the procedure. A therapeutic echoendoscope with a 3.7-mm or 3.8-
mm channel is recommended, because larger-bore accessories are
needed for dilation and stenting. High-resolution ﬂuoroscopy
requirements are no different than for ERCP.Table 2 Classiﬁcation of EUS-guided Biliary Interventions
Anterograde–retrograde access and downstream drainage
(EUS-guided rendezvous procedure)
Anterograde access and downstream transductal drainage
EUS-guided anterograde transpapillary stent placement
EUS-guided anterograde transanastomotic stent placement
Anterograde access and upstream transenteric drainage
EUS-guided hepaticogastrostomy
EUS-guided choledochoduodenostomy
EUS, endoscopic ultrasound.Strategies for EACP intervention
Three distinct strategies for EACP interventions are utilized,
depending on the bowel and biliary anatomy. In patients with an
endoscopically accessible papilla, EUS-guided transpapillary wire
placement for “rendezvous ERCP” can be performed. In patients in
whom the papilla cannot be accessed (e.g., gastric outlet obstruc-
tion, or surgical bypass), direct EUS-guided therapy is feasible. This
can either be anterograde-downstream across the obstruction, or
anterograde-upstream drainage across the bowel wall (Table 2).
Transhepatic versus transduodenal drainage
The left hepatic duct is accessed by the transgastric–trans-
hepatic route and the extrahepatic bile duct by the transduodenal
route. The transhepatic route has the advantage of affording greater
protection against complications of a bile leak (as is well known
from percutaneous transhepatic access). The extrahepatic route has
the advantage of easier, more direct access. This is usually at the
level of the duodenal bulb where the extrahepatic bile duct runs
along the duodenal bulb wall as it emerges from the pancreatic
head (the location used by surgeons to create a chol-
edochoduodenostomy). The portal vein is usually deep to the bile
duct and therefore not in the needle path. The choice of trans-
hepatic versus transduodenal access is often dictated by the site of
biliary obstruction (proximal vs. distal) and the bowel anatomy
(post-gastrectomy, or outlet obstruction).
Technique of bile duct access
It is helpful to assess ﬂuoroscopically the position of the
echoendoscope and the orientation of the exit path of the needle
before puncturing the duct. To access the left hepatic bile duct, the
scope is positioned in the proximal stomach along the lesser curve
(Fig. 1A,B). To access the extrahepatic bile duct, the scope is posi-
tioned in the duodenal bulb (Fig. 2A,B). In the bulb, the echoen-
doscope may be in the ‘‘long’’ or the ‘‘short’’ position, depending on
the desired orientation of the needle. In the long position the
needle orients towards the upstream bifurcation, whereas in the
short position the needle orients towards the downstream ampulla.
Generous inﬂation of the balloon is helpful when the scope is in the
short position to stabilize the position and help prevent the scope
from falling back into the stomach.
EUS-guided ductal puncture is performed with a 19-gauge or
22-gauge needle using a curvilinear echoendoscope. The 19-gauge
needle is generally preferred due to its ability to accommodate
larger-diameter wires. After puncture, aspiration of bile through
the needle is performed to conﬁrm intraductal position and to
decompress the relative high pressure system. Aspiration is fol-
lowed by contrast injection to provide a cholangiogram. A guide-
wire is advanced through the FNA needle. For a rendezvous
procedure, the wire is directed across the papilla or surgical anas-
tomosis and allowed to loop generously within the bowel. Leaving
the wire in place, the echoendoscope is removed and exchanged for
a duodenoscope (or enteroscope) inserted alongside the wire. The
wire is retrieved using a grasping forceps or snare (Fig. 3A,B), and
a transpapillary stent inserted (Fig. 3C).
Direct anterograde therapy can be performed either down-
stream across the obstruction and/or ampulla or upstream across
the bowel wall. Standard 0.035 inch instrumentation wires and
ERCP accessories (cannulas, dilating catheters and balloons) are
used. For downstream drainage, self-expandable metal stents
(SEMSs) are generally preferred over plastic stents owing to their
thinner proﬁle during insertion. The ﬁnal stent deployment posi-
tion should be nearly identical to that at ERCP. For upstream
Fig. 1. (A) Radiological and (B) ultrasound views of transgastric–transhepatic access of
the left hepatic bile duct. The scope is positioned in the proximal stomach along the
lesser curvature Arrow ¼ needle. Fig. 2. (A) Radiological and (B) ultrasound views of transduodenal access of the
common bile duct. The scope is positioned in the duodenal bulb. Arrow ¼ guidewire.
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preference.
If one strategy for EACP intervention fails, crossover to an
alternative strategy is usually feasible. For instance, in a post-
surgical bypass patient failing direct EUS therapy, a wire can be
advanced as far into the afferent limb as possible to facilitate
retrograde ERCP using deep enteroscopy (double-balloon assisted).
Similarly, patients failing EUS-rendezvous ERCP due to inability to
advance the wire across a site of obstruction can undergo direct
EUS therapy, such as placement of a transenteric stent for drainage.Transpapillary rendezvous procedure
The rendezvous procedure is derived from the percutaneous
technique whereby a guidewire is passed anterogradely across the
stricture and papilla (or surgical anastomosis) for subsequent
rendezvous retrograde drainage by ERCP (Fig. 2A, Fig. 3A–C).9 The
rendezvous procedure is limited by two requirements: (1) an
endoscopically accessible papilla (or bilioenteric anastomosis); and
(2) successful passage of the guidewire across the stricture into the
downstream small bowel. Percutaneous access under ﬂuoroscopic
guidance is substituted for transgastric or transduodenal access
under EUS guidance. This procedure minimizes the role of inter-
ventional radiology and should be considered an advanced cannu-
lation technique for ERCP.Over 200 cases of successful EUS-guided rendezvous procedures
performed for pancreatobiliary obstructions have been reported in
the literature (Table 3). Success rates vary between 35% and 98% in
the largest cases series. EUS-guided puncture of the duct and duc-
tography are accomplished in most cases. Failure is mainly due to
inability to steer a guidewire across the stricture. A rescue upstream
transenteric drainage is then performed to drain the obstructed
duct. When combining attempted EUS-guided rendezvous and
upstream drainage in cases of failure, the overall drainage success
rate is 87%. The reported complication rates are 12–17% and include
bile leaks, self-resolving pneumoperitoneum, subcapsular hema-
toma, and postprocedural pancreatitis.Downstream transductal drainage
This strategy is derived from percutaneous internal stent
drainage performed by interventional radiologists.10,11 The prereq-
uisite for downstream drainage is the successful traversement of
the obstruction with a guidewire. We have reported a series of ﬁve
patients who underwent anterograde biliary SEMS placement
because of nontraversable high-grade duodenal strictures (n ¼ 4)
and an endoscopically unreachable hepaticojejunostomy (n ¼ 1).12
The SEMS was successfully deployed with a decrease in bilirubin
levels in all cases. No postprocedural complications were noted
Fig. 3. Transpapillary rendezvous procedure: (A) the wire exits the papilla and is retrieved with (B) a grasping forceps. (C) A metal stent is placed for transpapillary drainage.
Gastrointestinal Intervention 2012 1(1), 11–1814after a median follow-up of 9.2 months. Puspok et al13 have previ-
ously described a successful EUS-guided transhepatic SEMS in
a single patient with a malignant biliary obstruction following
gastrectomy and Roux-en-Y anastomosis. Bories et al14 successfully
placed a SEMS transhepatically and under EUS guidance in two
patients. However, these procedureswere performed in a two-stage
fashionwith initial creation of a hepaticogastrostomy tract followedTable 3 Studies Evaluating EUS-guided Rendezvous Interventions
Author (y) No. of cases Successful
rendezvous ac
Mallery (2004)5 2 2 (100%)
Kahaleh (2004)19 5 3 (60%)
Kahaleh (2005)6 6 4 (67%)
Kahaleh (2006)20 23 18 (78%)
Tarantino (2008)21 9 4 (44%)
Brauer (2009)8 12 4 (33%)
Maranki (2009)22 49 32 (65%)
Own data (Shah, 2012)23 52 39 (75%)
Dhir (2012)24 58 57 (98%)
EUS, endoscopic ultrasound.by anterograde placement of a SEMS in a second separate
procedure.
Our success with anterograde drainage for malignant obstruc-
tion has led us to apply a similar approach for benign disease. An
alternative toERCP is particularlyattractive in thepostgastric bypass
patient harboring biliary stones. Hurdles to successful ERCP include
the need for deep enteroscopy to reach the ampulla, difﬁcult bilecess
Successful
biliary drainage
Procedural
complications
2 (100%) Transient fever (1)
4 (80%) None
5 (83%) None
21 (91%) Bleeding (1)
Bile leak (1)
Pneumoperitoneum (2)
9 (100%) None
11 (91%) None
41 (84%) Bleeding (1)
Bile leak (1)
Pneumoperitoneum (4)
39 (75%) Pancreatitis (2)
Subcapsular hematoma (1)
57 (98%) Bile leak (1)
Contrast leak (2)
Table 4 Studies Evaluating EUS-guided Downstream Transductal Interventions
Author (y) No. of cases Puncture and
dilation device
Access route Technical
success (%)
Procedural complications
Puspok (2005)13 1 19G needle Transgastric 100 None
Bories (2007)14 2 19G/22G needle Transgastric 100 None
Own data (Weilert, 2011)15 6 (Stones) 19G needle Transhepatic (4/6) 67 Subcapsular hematoma (1)
Park (2012)16 1 19G needle Crossover to DBE Rendezvous (2/6) 33 None
Own data (Nguyen-Tang, 2010;
Shah, 2012)12,23
10 (Strictures) 19G needle Transhepatic 100 None
Transgastric 100
EUS, endoscopic ultrasound; DBE, double balloon enteroscopy.
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imposed by a longer length and smaller channel size of the
enteroscope. We reported technical success of EUS-guided antero-
grade balloon sphincteroplasty and anterograde stone extraction in
4/6 patients.15 Park et al16 have described a case report of EUS-
guided transhepatic anterograde balloon dilation for a benign bil-
ioenteric anastomotic stricture. The available data on EUS-guided
downstream transductal interventions are summarized in Table 4.Fig. 4. (A) Radiological and (B) endoscopic views of upstream transgastric–trans-
hepatic drainage using an 8.5 Fr plastic stent (arrow).Upstream transenteric drainage
Upstream transenteric drainage is performed when the stric-
ture cannot be traversed with a wire or when the ampulla or
surgical anastomosis cannot be reached with an endoscope.
Creating a ﬁstula upstream from the obstructing stricture may
afford longer stent patency rates due to the elimination of tumor
ingrowth and overgrowth. There are pros and cons to using plastic
and metal stents, both covered and uncovered. A long plastic stentFig. 5. (A) Radiological and (B) endoscopic views of upstream transgastric–trans-
hepatic drainage using a fully covered metal stent with a 7 Fr single pigtail (arrow)
stent for anchorage.
Table 5 Studies Evaluating EUS-guided Hepaticogastric Drainage
Author (y) No. of cases Puncture and
dilation devices
Stent
placed
Technical
success (%)
Clinical
success (%)
Procedural
complications
Burmester (2003)25 1 Fistulotome Plastic 100 100 None
Giovannini (2003)26 1 19G needle Plastic 100 100 None
needle knife
Kahaleh (2006)20 1 19G/ 22G needle Plastic 100 100 None
Artifon (2007)27 1 19G needle SEMS 100 100 None
Will (2007)28 4 19G needle SEMS 100 75 Cholangitis (1)
6Fr bougie and 4- or
6-mm balloon
Bories (2007)14 11 19G/22G needle Plastic (7) 91 100 Ileus (1)
6 or 8.5Fr cystotome SEMS (3) Stent occlusion (1)
Biloma (1)
Cholangitis (1)
Maranki (2010)22 3 19G/22G needle Plastic 100 100 Unknown
Eum (2010)29 4 19G needle SEMS 100 100 None
Park (2011)30 31 19G needle Plastic (6) 100 87 Bleeding (1)
Own data Shah (2012)23 8 19G needle SEMS (25) 100 100 Pneumoperitoneum (5)
3 19G needle Plastic 100 100 Bacteremia (1)
SEMS None
EUS, endoscopic ultrasound; SEMS, self-expandable metal stent.
Gastrointestinal Intervention 2012 1(1), 11–1816(Fig. 4A,B) can generously straddle the hepatogastric wall without
blocking drainage of duct radicals, but may be more prone to
clogging than a SEMS. A covered metal stent (Fig. 5A,B) should
provide an effective seal against leakage of bile between the liver
and stomach, but the covering may block drainage of side ducts
and there may be a higher risk of migration. Uncovered stents
anchor well, but bile leakage across the open mesh is a signiﬁcant
concern. Our preference has generally been to place a plastic stent
, but in select patients we have used a fully covered metal stent
with a long plastic pigtail stent inserted through the lumen to
prevent migration (Fig. 5B). An alternative strategy is ﬁrst to place
a straight plastic stent and exchange this several weeks later (after
a mature tract has formed) over the wire for an uncovered SEMS.
Larger series with longer follow-up are needed to determine the
optimal drainage strategy using plastic and metal stents. TheTable 6 Studies Evaluating EUS-guided Choledochoduodenal Drainage
Author (y) No. of cases Puncture and
dilation devices
Giovannini (2001)31 1 Needle knife
Dilating catheter
Burmester (2003)25 2 Fistulotome
Puspok (2003)13 5 Needle knife
Kahaleh (2006)20 1 19G needle
Fujita (2007)32 1 19G needle
Dilating catheter
Ang (2007)33 2 Needle knife
Dilating catheter
Yamao (2008)34 5 Needle knife
Dilating catheter
Tarantino (2008)21 4 19G/22G needle
Balloon dilation
Itoi (2008)35 4 19G needle or needle knife
Dilating catheter or balloon dila
Maranki (2009)22 4 19G needle
Dilating catheter or balloon dila
Brauer (2009)8 3 19G/22G needle
Own data Nguyen-Tang (2009)36 2 Needle knife
Hara K (2011)37 18 19G needle
19G needle
Park (2011)30 24 Dilating catheter needle knife
EUS, endoscopic ultrasound; SEMS, self-expandable metal stent.available data on EUS-guided hepaticogastrostomy is summarized
in Table 5. Over 50 cases have been reported in the literature with
a high rate of technical success exceeding 90%. The overall
complication rate is 22% and includes cholangitis, bilioma, ileus,
and stent occlusion. Both plastic and metal stents have been used
for transenteric drainage. Bories et al14 have reported two cases of
peritoneal leak caused by shortening of the metal stent after
deployment.
The available data on EUS-guided choledochoduodenostomy are
summarized in Table 6. More than 75 cases have been reported and
the overall success rate of the procedure is high (89%) but a high
complication rate (21%) is also noted. The reported complications
include pneumoperitoneum (n ¼ 5; 15%) and bile leak (n ¼ 2; 6%).
In the majority of cases plastic stents were used to drain the
common bile duct into the duodenum.Stent placed Technical
success (%)
Clinical
success (%)
Procedural
complications
Plastic 100 100 None
Plastic 50 100 Bile peritonitis (1)
Plastic 80 100 None
SEMS 100 100 Pneumoperitoneum (1)
Plastic 100 100 None
Plastic 100 100 Pneumoperitoneum (1)
Plastic 100 100 Pneumoperitoneum (1)
Plastic 100 100 None
Plastic 100 100 Bile peritonitis (1)
tion
NA NA NA NA
tion
Plastic 100 100 Pneumoperitoneum (1)
SEMS 50 100 Pneumoperitoneum (1)
Plastic 94 100 Bile peritonitis (1)
Plastic/SEMS 92 92 Hemobilia (1)
SEMS 100 100 Bile peritonitis (2)
Pneumoperitoneum (2)
Bleeding (1)
None
Fig. 6. Fully covered expandable lumen-apposing stent (AXIOS).
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adherence between the stomach and the liver. A shift in the position
of the liver relative to the stomach wall may cause the stent to
dislocate, resulting in abile leak into theperitoneal space. The lackof
adherence also increases the risk of bleeding from the liver surface.
Similarly, the main drawback of a choledochoenterostomy is the
absence of adherence between the bile duct and the bowel wall. As
seen from the literature, there is a very high risk of bile leak and
pneumoperitoneum. Compounding this, intraductal pressures are
higher in the extrahepatic bile duct than in the intrahepatic duct.
This is compensated for by decompression after initial puncture.
Postsurgical anatomy can pose obvious limitations for trans-
enteric drainage. Left hepatectomy eliminates transhepatic access,
and prior gastrojejunostomy or biliary bypass surgery (hep-
aticojejunostomy) eliminates extrahepatic access.
Future developments
Tubular stents that are currently used to accomplish endoscopic
transluminal drainage do not impart lumen-to-lumen anchorage.
What is needed is a lumen-apposing stent that enables the creation
of a leak-proof conduit between nonadherent lumens such as the
bile duct and the duodenum (choledochoduodenostomy). In the
porcine model, a fully covered expandable lumen-apposing stent
(AXIOS; Xlumena Inc., Mountain View, CA, USA) was tested and
found to create a safe, durable, leak-free conduit (Fig. 6). The stent
was easily removedwith a snare at 4 weeks.17 Future developments
should enable the integration of the multiple steps required to
achieve transluminal ductal drainage into a single catheter-based
device. After lumen access, tract dilation and stent deployment
occurs seamlessly in a coaxial fashion without instrument
exchanges. Itoi et al18 have used these lumen-apposing stents
successfully in pseudocyst and gallbladder drainage.
A recent modiﬁcation of the conventional FNA needle (EchoTip
Ultra Access Needle; Cook Endoscopy, Winston–Salem, NC, USA)
enables easier wire manipulation after bile duct access is achieved.
The modiﬁed needle has a sharp beveled stylet that protrudes
beyond a blunt needle tip. After the needle enters the bile duct the
stylet is removed, thereby converting the tip to a blunt conﬁgura-
tion. This allows for easier to-and-fro wire manipulations and
prevents “stripping” of the hydrophilic wire coating or wire tran-
section that can occur with standard sharp-tip EUS needles. Other
modiﬁcations of tools available to our interventional radiologists
such as “steerable sheaths” and a greater variety of guidewires may
further facilitate success in EACP procedures.
Conclusion
Over recent years, we have seen the emergence of EACP as
a viable strategy to achieve drainage of the bile when ERCP is notfeasible or fails. For biliary drainage, EACP has numerous theoretical
advantages overPTBD. The literature supports the feasibility of EACP
with high technical success. Complication rates have been high,
however, the safety proﬁle of EACP is improving with increasing
experience. It must be emphasized that the tools used to perform
EACP have been borrowed from ERCP and other sectors of inter-
ventional endoscopy. Tools designed for EUS-guided applications
that enable safer transenteric access and drainage are being devel-
oped. The input from innovative device manufacturers is critical at
this stage. Training is a second issue that will need to be addressed.
The complexity of EACP requires the highest levels of training in
both EUS and ERCP. Training programs in pancreaticobiliary
endoscopy must integrate the two procedures if EACP is to become
widely accepted.
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